3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
3
Unknown
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Genitourinary
1
CNS
1
Conditions
Pancreatic Neoplasms
78
Carcinoma, Non-Small-Cell Lung
43
Nasopharyngeal Carcinoma
24
Lung Neoplasms
23
Breast Neoplasms
14
Cholangiocarcinoma
13
Lymphoma, Large B-Cell, Diffuse
12
Neoplasm Metastasis
11
Ovarian Neoplasms
10
Lymphoma, Extranodal NK-T-Cell
10
Recurrence
9
Biliary Tract Neoplasms
9
Urinary Bladder Neoplasms
7
Triple Negative Breast Neoplasms
6
Neoplasms
6
Nasopharyngeal Neoplasms
6
Lymphoma
6
Lymphoma, T-Cell, Peripheral
5
Uterine Cervical Neoplasms
4
Unspecified Adult Solid Tumor, Protocol Specific
4
Rectal Neoplasms
4
Hodgkin Disease
4
Head and Neck Neoplasms
4
Gallbladder Neoplasms
4
Colonic Neoplasms
4
Carcinoma, Transitional Cell
4
Adenocarcinoma of Lung
4
Sarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, T-Cell
3
Interventions
Radiotherapy
19
Temozolomide
11
Cisplatin
9
Vincristine
8
Chemotherapy, Adjuvant
8
Carboplatin
8
Etoposide
6
Lomustine
5
Methotrexate
4
Thiotepa
3
Peripheral Blood Stem Cell Transplantation
3
Magnetic Resonance Spectroscopy
3
Ifosfamide
3
Filgrastim
3
Cyclophosphamide
3
Carmustine
3
pegfilgrastim
2
Tamoxifen
2
Surgical Procedures, Operative
2
Psychiatric Rehabilitation
2
Pemetrexed
2
Mental Status and Dementia Tests
2
Hyperbaric Oxygenation
2
Ethanol
2
Erlotinib Hydrochloride
2
Dexamethasone
2
Amplified Fragment Length Polymorphism Analysis
2
nedaplatin
1
motexafin gadolinium
1
lonafarnib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Central Nervous System Neoplasms
×
Gemcitabine
×
Clear all
NCT00551122
2013-01-23
GemTIP
University of Southampton
Phase 1/2
Unknown
23 enrolled